152 related articles for article (PubMed ID: 25456131)
1. JNK suppresses tumor formation via a gene-expression program mediated by ATF2.
Gozdecka M; Lyons S; Kondo S; Taylor J; Li Y; Walczynski J; Thiel G; Breitwieser W; Jones N
Cell Rep; 2014 Nov; 9(4):1361-74. PubMed ID: 25456131
[TBL] [Abstract][Full Text] [Related]
2. Co-regulation of the transcription controlling ATF2 phosphoswitch by JNK and p38.
Kirsch K; Zeke A; Tőke O; Sok P; Sethi A; Sebő A; Kumar GS; Egri P; Póti ÁL; Gooley P; Peti W; Bento I; Alexa A; Reményi A
Nat Commun; 2020 Nov; 11(1):5769. PubMed ID: 33188182
[TBL] [Abstract][Full Text] [Related]
3. The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2.
Baan B; van Dam H; van der Zon GC; Maassen JA; Ouwens DM
Mol Endocrinol; 2006 Aug; 20(8):1786-95. PubMed ID: 16601071
[TBL] [Abstract][Full Text] [Related]
4. The nuclear appearance of ERK1/2 and p38 determines the sequential induction of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells.
Baan B; van der Zon GC; Maassen JA; Ouwens DM
Mol Cell Endocrinol; 2009 Nov; 311(1-2):94-100. PubMed ID: 19647037
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta and tetradecanoylphorbol acetate-induced biosynthesis of tumor necrosis factor alpha in human hepatoma cells involves the transcription factors ATF2 and c-Jun and stress-activated protein kinases.
Bauer I; Al Sarraj J; Vinson C; Larsen R; Thiel G
J Cell Biochem; 2007 Jan; 100(1):242-55. PubMed ID: 16888805
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
7. TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation.
Li M; Zhang D; Ge X; Zhu X; Zhou Y; Zhang Y; Peng X; Shen A
Exp Cell Res; 2019 Mar; 376(2):133-148. PubMed ID: 30763583
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic.
Liu S; Wang F; Yan L; Zhang L; Song Y; Xi S; Jia J; Sun G
Arch Toxicol; 2013 Jun; 87(6):981-9. PubMed ID: 23591579
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma protein interacts with ATF2 and JNK/p38 in stimulating the transforming growth factor-beta2 promoter.
Li H; Wicks WD
Arch Biochem Biophys; 2001 Oct; 394(1):1-12. PubMed ID: 11566021
[TBL] [Abstract][Full Text] [Related]
10. The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
Gozdecka M; Breitwieser W
Biochem Soc Trans; 2012 Feb; 40(1):230-4. PubMed ID: 22260696
[TBL] [Abstract][Full Text] [Related]
11. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
12. Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells.
Breitwieser W; Lyons S; Flenniken AM; Ashton G; Bruder G; Willington M; Lacaud G; Kouskoff V; Jones N
Genes Dev; 2007 Aug; 21(16):2069-82. PubMed ID: 17699753
[TBL] [Abstract][Full Text] [Related]
13. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Hayakawa J; Depatie C; Ohmichi M; Mercola D
J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
[TBL] [Abstract][Full Text] [Related]
14. The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis.
Zhang JY; Jiang H; Gao W; Wu J; Peng K; Shi YF; Zhang XJ
Cell Mol Life Sci; 2008 May; 65(9):1435-45. PubMed ID: 18385943
[TBL] [Abstract][Full Text] [Related]
15. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
[TBL] [Abstract][Full Text] [Related]
16. Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells.
Aggeli IK; Gaitanaki C; Beis I
Cell Signal; 2006 Oct; 18(10):1801-12. PubMed ID: 16531007
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
18. GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2.
Thévenin AF; Zony CL; Bahnson BJ; Colman RF
Protein Sci; 2011 May; 20(5):834-48. PubMed ID: 21384452
[TBL] [Abstract][Full Text] [Related]
19. Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL.
Salameh A; Galvagni F; Anselmi F; De Clemente C; Orlandini M; Oliviero S
J Biol Chem; 2010 Jul; 285(30):23096-104. PubMed ID: 20507983
[TBL] [Abstract][Full Text] [Related]
20. Enzyme kinetics and interaction studies for human JNK1β1 and substrates activating transcription factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun).
Figuera-Losada M; LoGrasso PV
J Biol Chem; 2012 Apr; 287(16):13291-302. PubMed ID: 22351776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
